Logo of TCD Capital, which leads to the homepage when clicked.
Sector: Life Sciences
Fund: Fund II
Team: Attila Borbáth, Pascal Doguet


Synergia Medical is pioneering optoelectronics for neural stimulation therapies by developing an innovative, powerful and versatile neural stimulation technological platform.

By doing so, Synergia Medical will improve patients’ quality of life and pave the way to new personalized therapies.

Full range of applications
Synergia Medical’s technology could benefit numerous neurological diseases such as chronic pain, Parkinson’s disease, drug-resistant epilepsy, sleep apnoea and depression.

Synergia Medical’s current IP portfolio includes non-metallic encapsulation of neurostimulators, fast-charging wireless system, a custom optical lead, miniaturized photovoltaic cells and an enhanced electrode.

Our Alliance

Investment Managers

Other investments in Life Sciences

Other investments in Fund II

Subscribe to our Newsletter

We seek to customise the content to the segments we serve.

These are both fund investors and the entrepreneurs with whom we have created alliances.

We are happy to keep in touch.

TCD Form Template Style